Finance

Lists
INM:NASDAQ
InMed Pharmaceuticals Inc
1,38 $
+1,10%
(+0,015) 1D
29 սեպ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INM...
Open
1,35 $
High
1,42 $
Low
1,34 $
Mkt. cap
7,55 մլն
Avg. vol.
79,18 հզր
Volume
0,00
52-wk high
2,50 $
52-wk low
0,58 $
EPS
-2,73 $
Beta
0,98
Shares outstanding
5,49 մլն
No. of employees
13
Open
1,35 $
High
1,42 $
Low
1,34 $
Mkt. cap
7,55 մլն
Avg. vol.
79,18 հզր
Volume
0,00
52-wk high
2,50 $
52-wk low
0,58 $
EPS
-2,73 $
Beta
0,98
Shares outstanding
5,49 մլն
No. of employees
13
About InMed Pharmaceuticals Inc
CEOEric A. Adams
Employees13
Founded1981
HeadquartersՎանքուվեր, Բրիտանական Կոլումբիա, Կանադա
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
1,30 մլն
1,12 մլն
820,19 հզր
-
Cost of goods sold
728,06 հզր
716,96 հզր
635,99 հզր
-
Cost of revenue
728,06 հզր
716,96 հզր
635,99 հզր
-
Research and development expenses
112,72 հզր
581,61 հզր
630,64 հզր
1,02 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,25 մլն
1,53 մլն
1,62 մլն
1,74 մլն
Operating expense
2,42 մլն
2,17 մլն
2,30 մլն
2,82 մլն
Total operating expenses
3,15 մլն
2,88 մլն
2,94 մլն
2,82 մլն
Operating income
-1,84 մլն
-1,76 մլն
-2,12 մլն
-2,82 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-1,79 մլն
-1,73 մլն
-2,03 մլն
-2,79 մլն
EBT excluding unusual items
-1,79 մլն
-1,73 մլն
-2,03 մլն
-2,79 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,79 մլն
-1,73 մլն
-2,03 մլն
-2,97 մլն
Net profit margin
-137,07%
-154,17%
-247,29%
-
Earnings per share
-
-
-
-
Interest and investment income
51,69 հզր
93,76 հզր
74,38 հզր
47,77 հզր
Interest expense
-20,00 հզր
-
-
-
Net interest expenses
31,69 հզր
93,76 հզր
74,38 հզր
47,77 հզր
Depreciation and amortization charges
52,75 հզր
53,20 հզր
53,20 հզր
51,71 հզր
EBITDA
-1,79 մլն
-1,71 մլն
-2,07 մլն
-2,77 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps